Loading…
This event has ended. View the official site or create your own event → Check it out
This event has ended. Create your own
View analytic
Monday, June 19 • 8:30am - 10:00am
#101: Drug Repurposing: Where Will it Take Us?

Sign up or log in to save this to your schedule and see who's attending!

Feedback form is now closed.
Component Type: Forum
Level: Intermediate
CE: ACPE 1.50 Knowledge UAN: 0286-0000-17-562-L04-P; CME 1.50; IACET 1.50; RN 1.50

Drug repurposing includes approved drug indication expansion, drug-like compound repositioning, and drug reformulation strategies to help get medicines to patients faster. Because repositioning leverages sunk costs for compounds that have failed to reach market, and approved drugs can be reformulated or repurposed to treat a different disorder, the cost often times to get the new therapy to market is reduced. Will “repurposing" disrupt the current market? How can academia, industry, and health authorities collaborate to advance drug repurposing efforts? What is needed to overcome economic, patent, and regulatory hurdles to get repurposed drugs to patients faster? These questions and others will be addressed during this DIAmond session by an esteemed panel of representatives from NIH NCATS, Cures Within Reach, industry, and academia.

Learning Objectives

Define the concept of drug repurposing; Discuss opportunities and challenges for academia, industry, and health authorities to collaborate to advance drug repurposing efforts; Review the economic, patent, and regulatory hurdles that exist to get repurposed drugs to patients faster.

Chair

Bruce E Bloom, DDS, JD

Speaker

Funder Perspective
Christine Colvis, PhD

Using Human Genetic Variation to Repurpose Existing Medications for New Diseases
Jill Pulley, MBA

Industry Perspective
Pamela Hill, MS, PMP

Industry Perspective
K. Gary Barnette, PhD



Speakers
avatar for K. Gary Barnette

K. Gary Barnette

Senior Vice President of Scientific and Regulatory Affairs, Camargo Pharmaceutical Services, LLC
With more than 20 years of industry experience, Dr. K. Gary Barnette brings to Camargo a wealth of knowledge of FDA regulations. At Camargo, Barnette is responsible for propelling the growth of the company and establishing excellent customer service practices by utilizing his sub... Read More →
avatar for Bruce Bloom

Bruce Bloom

President and Chief Science Officer, Cures Within Reach
Dr. Bruce Bloom is President and Chief Science Officer of Cures Within Reach, a non-profit saving lives using its CureAccelerator™ platform repurposing approved drugs/devices to quickly deliver safe and affordable treatments for unsolved diseases. He is an Ashoka Fellow, Patien... Read More →
avatar for Christine Colvis

Christine Colvis

Director, Drug Development Partnership Programs, National Center for Advancing Translational Sciences (NCATS)
Christine Colvis joined NCATS in June 2012 as the Center’s director of drug development partnership programs. Her team is best known for leading the Discovering New Therapeutic Uses for Existing Molecules (New Therapeutic Uses) program, which supports pre-clinical and clinical... Read More →
avatar for Pamela Hill

Pamela Hill

Open Innovation Program Director, Principal Scientist, Emerging Innovations Unit, AstraZeneca
With more than 15 years of experience in the biopharmaceutical industry, Pam Hill has worked in the discovery phase supporting multiple therapy areas and brought mulitple drugs into clincial studies. Hill is currently leading the Open Innovation program at AstraZeneca which has r... Read More →
avatar for Jill Pulley

Jill Pulley

Executive Director, Vanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center
Jill Pulley has focused her career on providing disease-neutral, large-scale infrastructure so that researchers can initiate and conduct high quality translational science in a compliant, efficient, and cost effective manner. She is Executive Director of the Vanderbilt Institute... Read More →


Monday June 19, 2017 8:30am - 10:00am
S105 McCormick Place 2301 South Martin Luther King Jr. Drive, Gate 4 Chicago, IL 60616
  • format json
  • Featured Topics Academic Clinical Researcher,Public Policy,Rare Disease,StudentProgramming
  • Credit Type ACPE, CME, IACET, RN
  • Tags Forum